Aurora Spine Corporation (TSXV:ASG)
Canada · Delayed Price · Currency is CAD | Market Cap | 7.81M -66.7% |
| Revenue (ttm) | 24.92M -4.5% |
| Net Income | -1.73M |
| EPS | -0.02 |
| Shares Out | 78.09M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | 0.1000 |
| Day's Range | n/a |
| 52-Week Range | 0.0950 - 0.3250 |
| Beta | -0.27 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 16, 2026 |
About Aurora Spine
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone lumbar fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic pro... [Read more]
Financial Performance
In 2025, Aurora Spine's revenue was $18.37 million, an increase of 4.58% compared to the previous year's $17.56 million. Losses were -$731,120, -27.08% less than in 2024.
Financial numbers in USD Financial StatementsNews
Aurora Spine Announces Publication of REFINE Study's 12-Month Results in the International Journal of Spine Surgery
Peer-reviewed publication adds prospective, multicenter clinical evidence for the ZIP MIS Interlaminar Fusion System Carlsbad, California--(Newsfile Corp. - October 22, 2026) - Aurora Spine Corporatio...
Aurora Spine Corporation Announces Amendment to Loan from Insider
Carlsbad, California--(Newsfile Corp. - September 29, 2026) - Aurora Spine Corporation (TSXV: ASG) ("Aurora Spine" or the "Company") announced today that an insider of the Company has agreed to increa...
Aurora Spine Earnings Call Transcript: Q2 2026
Q2 revenue declined 18.7% year-over-year due to sales team restructuring and SI joint market competition, but spine segment sales grew, led by DEXA products. Management expects improved performance in the second half, supported by a new alliance with CornerLoc and ongoing sales team expansion.
Aurora Spine MD&A: Q2 2026
Aurora Spine filed a regulatory document on August 27, 2026 disclosing important business information.
Aurora Spine Report: Q2 2026
Aurora Spine published a report on August 27, 2026 containing material business information for investors and shareholders.
Aurora Spine Earnings release: Q2 2026
Aurora Spine released its Q2 2026 earnings on August 27, 2026, summarizing the period's financial results.
Aurora Spine Corporation Announces Second Quarter FY26 Financial Results
- Company to host conference call Today, August 27th at 11am ET/8am PT - NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Carlsbad, California--(Newsfile Corp. - August 27...
Aurora Spine Announces Settlement of Arbitration, New Patent License Agreement for SI Joint Product and Increase in Funding from Insider
Carlsbad, California--(Newsfile Corp. - August 14, 2026) - Aurora Spine Corporation (TSXV: ASG) ("Aurora Spine" or the "Company") announced today that it has entered into a new non-exclusive license t...
Aurora Spine and CornerLoc Announce Strategic Commercial Alliance to Expand Minimally Invasive Spine and SI Joint Solutions Nationwide
Carlsbad, California and Tulsa, Oklahoma--(Newsfile Corp. - July 16, 2026) - Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groun...
Aurora Spine Transcript: Lytham Partners Spring 2026 Investor Conference
Proprietary spine products simplify procedures, expand patient access, and drive revenue growth, with ZIP and SiLO lines leading innovation. DEXA technology addresses bone density needs, while a new biologics division and upcoming product launches support a comprehensive portfolio.
Aurora Spine Slides: FY 2026
Aurora Spine has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 28, 2026.
Aurora Spine Earnings Call Transcript: Q1 2026
Q1 2026 saw modest revenue growth and a significant margin improvement, driven by proprietary product sales and a strengthened sales team. New product launches and expanded regional coverage are expected to accelerate growth in the second half of the year.
Aurora Spine MD&A: Q1 2026
Aurora Spine filed a regulatory document on May 28, 2026 disclosing important business information.
Aurora Spine Report: Q1 2026
Aurora Spine published a report on May 28, 2026 containing material business information for investors and shareholders.
Aurora Spine Earnings release: Q1 2026
Aurora Spine released its Q1 2026 earnings on May 28, 2026, summarizing the period's financial results.
Aurora Spine Corporation Announces First Quarter FY26 Financial Results
- Company to host conference call Today, May 28th at 10am ET/7am PT – - Company to host conference call Today, May 28th at 10am ET/7am PT –
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results
- Company to Participate in the Lytham Partners Spring 2026 Investor Conference - - Company to Participate in the Lytham Partners Spring 2026 Investor Conference -
Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants
CARLSBAD, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices ...
Aurora Spine Earnings Call Transcript: Q4 2025
Record annual and Q4 revenues driven by ZIP, SiLO, and DEXA-L launches, with gross margin improvement and narrowed net loss. Expanded sales force and new product launches position the company for continued growth and cash flow positivity in 2026.
Aurora Spine Report: Q4 2025
Aurora Spine published a report on April 30, 2026 containing material business information for investors and shareholders.
Aurora Spine MD&A: Q4 2025
Aurora Spine filed a regulatory document on April 30, 2026 disclosing important business information.
Aurora Spine Earnings release: Q4 2025
Aurora Spine released its Q4 2025 earnings on April 30, 2026, summarizing the period's financial results.
Aurora Spine Corporation Announces Record Fourth Quarter and FY25 Financial Results
– Q4 revenue surpasses $5 million threshold – –Company to host conference call today, April 30th at 11am ET/8am PT –
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2025 Financial Results
CARLSBAD, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical device...
Aurora Spine Corporation to Participate in the 38th Annual ROTH Conference
CARLSBAD, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical device...